Yuhan Corporation

Eun Hye Jung

Na Ry Ha

Hyun Ho Choi

Dong Hoon Kim

Sol Park

Tae Dong Han

Eun Kyung Kim

Su Bin Choi

Hee Jae Tak

Mi Kyeong Ju

Tae Wang Kim

Do Hoon Kim

Tae Kyun Kim

Jun Chul Park

Ji Yeong Gal

Jae Won Jeong

Hyun Seung Lee

Jae Eun Joo

Da In Chung

Ji Eun Yang

Sang Myoun Lim

Jun Chui Park

Tae Han Dong

Yoo Hoi Park

The present technology provides pyrrolidine and piperidine compounds or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. In particular, said compounds may be usefully applied in the treatment and prevention of FAP-mediated diseases.

Pyrrolidine and piperidine compounds

The present technology provides aryl or heteroaryl triazolone derivatives or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and the use thereof. The aryl or heteroaryl triazolone derivatives or their pharmaceutically acceptable salts exhibit selective inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).

Aryl or heteroaryl triazolone derivatives or salts thereof, or pharmaceutical compositions comprising the same

Growing community of inventors

Yongin-si, South Korea

Eun Hye Jung